Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
GE Healthcare clinical trials
Also known as GEHC.
The registry lists 182 studies whose lead sponsor is GE Healthcare or one of 3 companies grouped under it. 21 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 16, 2026.
Keep track of what changes. Save the GE Healthcare studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to GE Healthcare.
- GE Healthcare175 studiesSame company
Something wrong?
- Caption Health, Inc.4 studies →Acquired — became part of GE Healthcare, Feb 17, 2023 · source ↗
Something wrong?
- 2 studies →
- Nihon Medi-Physics Co., Ltd.1 study →Acquired — became part of GE Healthcare, Mar 31, 2025 · source ↗
Something wrong?
Focus areas
Conditions GE Healthcare leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 182. Browse all 182 →
- Flutemetamol F 18 Injection Formulation ComparisonNot yet recruitingNCT07873463Phase 2
- Positron Emission Tomography/Computed Tomography (PECT/CT) Double-Scanning StudyRecruitingNCT07857161
- Automated Non-Invasive Blood Pressure StudyRecruitingNCT07790458
- Data Collection of New Spectral CT Imaging MethodRecruitingNCT07661706
- Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning StudyRecruitingNCT07725237
- NIBP Accuracy Study for Adult Subject PopulationsRecruitingNCT07697950Not applicable
- Non-Invasive Blood Pressure Accuracy Study for Adult Subject PopulationsRecruitingNCT07628296Not applicable
- NMT EasyFit Sensor and CableRecruitingNCT07394140Not applicable
- NIBP Study for Neonate and Pediatric Subject PopulationsRecruitingNCT07684885Not applicable
- SpO2 Infant and Pediatric StudyNot yet recruitingNCT07615738Not applicable
- A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult PatientsRecruitingNCT07472491Phase 2/3
- Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)RecruitingNCT07219238Phase 2/3
- Portrait Mobile Monitoring Solution V2.0 External EvaluationNot yet recruitingNCT07309809Not applicable
- A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric PatientsRecruitingNCT04604782Phase 1/2
- Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver ImagingRecruitingNCT06639828Phase 4
- Point of Care Lung Ultrasound Examination in Patients With Shortness of BreathEnrolling by invitationNCT07046234Not applicable
- Clinical Performance Evaluation of a Diagnostic Ultrasound SystemRecruitingNCT07066449
- CARESCAPE Monitoring Systems ME StudyEnrolling by invitationNCT07024459Not applicable
- Feasibility of a Deep Learning-based Algorithm for Non-invasive Assessment of Vulnerable Coronary PlaqueNot yet recruitingNCT06186336
- A Validation Study to Evaluate the Performance of Caption Health Lung Guidance and InterpretationRecruitingNCT05992324Not applicable
Sponsor listed in the registry: Caption Health, Inc. · First submitted after Caption Health, Inc. became part of GE Healthcare
- Clinical Data Collection in Breast Tomosynthesis (COBRIS)RecruitingNCT05914168Not applicable
- Clinical Data Collection for Obstetric Ultrasound AlgorithmsSuspendedNCT06742229Not applicable
Sponsor listed in the registry: Caption Health, Inc. · First submitted after Caption Health, Inc. became part of GE Healthcare
- A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour MalignanciesTerminatedNCT05629689Phase 1
- Maternal Fetal Device Performance TwinsCompletedNCT06835647Not applicable
- GSI Cardiac on Revolution Apex - USActive, not recruitingNCT06702917
- Point-of-Care Echocardiography in Patients With Known or Suspected Aortic StenosisCompletedNCT06717373Not applicable
Sponsor listed in the registry: Caption Health, Inc. · First submitted after Caption Health, Inc. became part of GE Healthcare
- NIBP Accuracy Study for AdultWithdrawnNCT07684859
- Clinical Feasibility and Evaluation of Silicon Photon Counting CTCompletedNCT05838482
- Next Generation CT SystemCompletedNCT06769594
- Clinical Data Collection On Advanced CT SystemCompletedNCT05835284
- A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy VolunteersCompletedNCT06398730Phase 1
- Maternal Fetal Device Performance SingletonCompletedNCT06726343Not applicable
- Spectral CT With Advanced CT TechnologyCompletedNCT04781296Not applicable
- Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic CancerCompletedNCT06129422Phase 1
Sponsor listed in the registry: Nihon Medi-Physics Co., Ltd. · First submitted before Nihon Medi-Physics Co., Ltd. became part of GE Healthcare
- [18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential TremorCompletedNCT04265209Phase 3
- Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast CancerWithdrawnNCT05634954Phase 1
- Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast CancerActive, not recruitingNCT05486182Phase 4
- Altropane Dose for Imaging Patients With Suspected Parkinson's DiseaseTerminatedNCT05636852Phase 2
- Evaluation of the Goldcrest Patch PerformanceCompletedNCT06355453
- NIBP Cuff Comparison StudyCompletedNCT07024472
- Wireless Disposable SpO2 Sensor Hypoxia TestingCompletedNCT06211530Not applicable
- Carbon Dioxide InvestigationCompletedNCT06715410Not applicable
- A Study to Evaluate the Effectiveness of VIZAMYL™ Reader Training Programme in EuropeCompletedNCT04773015
- Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer PatientsTerminatedNCT05068726
- Clinical Data Collection and Evaluation of ECG-Less Cardiac CTCompletedNCT05949138
- Evaluation of a New Generation of PET-CT OMNICompletedNCT05154877
- Study to Determine Safety and Dosage of OPTISON in Pediatric ParticipantsCompletedNCT03740997Phase 4
- Dual Energy Cardiac CT Data Collection and EvaluationCompletedNCT05171764
- A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese PatientsCompletedNCT04193527Phase 3
- A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers.CompletedNCT04564092Phase 1